Literature DB >> 25940397

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility.

Daniele Campa1, Cosmeri Rizzato2, Rachael Stolzenberg-Solomon3, Paola Pacetti4, Pavel Vodicka5, Sean P Cleary6, Gabriele Capurso7, H B As Bueno-de-Mesquita8,9,10,11, Jens Werner12, Maria Gazouli13, Katja Butterbach14, Audrius Ivanauskas15, Nathalia Giese12, Gloria M Petersen16, Paola Fogar17, Zhaoming Wang3, Claudio Bassi18, Miroslav Ryska19, George E Theodoropoulos20, Charles Kooperberg21, Donghui Li22, William Greenhalf23, Claudio Pasquali24, Thilo Hackert12, Charles S Fuchs25, Beatrice Mohelnikova-Duchonova26, Cosimo Sperti24, Niccola Funel27, Aida Karina Dieffenbach14,28, Nicholas J Wareham29, Julie Buring30, Ivana Holcátová31, Eithne Costello23, Carlo-Federico Zambon32, Juozas Kupcinskas15, Harvey A Risch33, Peter Kraft34, Paige M Bracci35, Raffaele Pezzilli36, Sara H Olson37, Howard D Sesso30,34, Patricia Hartge3, Oliver Strobel12, Ewa Małecka-Panas38, Kala Visvanathan39, Alan A Arslan40, Sergio Pedrazzoli41, Pavel Souček42, Domenica Gioffreda43, Timothy J Key44, Renata Talar-Wojnarowska38, Aldo Scarpa45, Andrea Mambrini4, Eric J Jacobs46, Krzysztof Jamroziak47, Alison Klein48, Francesca Tavano43, Franco Bambi49, Stefano Landi50, Melissa A Austin51, Ludmila Vodickova5, Hermann Brenner14,28, Stephen J Chanock3, Gianfranco Delle Fave7, Ada Piepoli43, Maurizio Cantore4, Wei Zheng52, Brian M Wolpin25, Laufey T Amundadottir3, Federico Canzian2.   

Abstract

A small number of common susceptibility loci have been identified for pancreatic cancer, one of which is marked by rs401681 in the TERT-CLPTM1L gene region on chromosome 5p15.33. Because this region is characterized by low linkage disequilibrium, we sought to identify whether additional single nucleotide polymorphisms (SNPs) could be related to pancreatic cancer risk, independently of rs401681. We performed an in-depth analysis of genetic variability of the telomerase reverse transcriptase (TERT) and the telomerase RNA component (TERC) genes, in 5,550 subjects with pancreatic cancer and 7,585 controls from the PANcreatic Disease ReseArch (PANDoRA) and the PanScan consortia. We identified a significant association between a variant in TERT and pancreatic cancer risk (rs2853677, odds ratio = 0.85; 95% confidence interval = 0.80-0.90, p = 8.3 × 10(-8)). Additional analysis adjusting rs2853677 for rs401681 indicated that the two SNPs are independently associated with pancreatic cancer risk, as suggested by the low linkage disequilibrium between them (r(2) = 0.07, D' = 0.28). Three additional SNPs in TERT reached statistical significance after correction for multiple testing: rs2736100 (p = 3.0 × 10(-5) ), rs4583925 (p = 4.0 × 10(-5) ) and rs2735948 (p = 5.0 × 10(-5) ). In conclusion, we confirmed that the TERT locus is associated with pancreatic cancer risk, possibly through several independent variants.
© 2015 UICC.

Entities:  

Keywords:  pancreatic cancer; polymorphisms; susceptibility; telomerase

Mesh:

Substances:

Year:  2015        PMID: 25940397      PMCID: PMC4548797          DOI: 10.1002/ijc.29590

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  50 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

Review 2.  Switching and signaling at the telomere.

Authors:  E H Blackburn
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

3.  ABO blood groups and cancer of oesophagus, cancerof pancreas, and pituitary adenoma.

Authors:  I AIRD; D R LEE; J A ROBERTS
Journal:  Br Med J       Date:  1960-04-16

4.  A new multipoint method for genome-wide association studies by imputation of genotypes.

Authors:  Jonathan Marchini; Bryan Howie; Simon Myers; Gil McVean; Peter Donnelly
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

5.  A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms.

Authors:  Xiaoyi Gao; Joshua Starmer; Eden R Martin
Journal:  Genet Epidemiol       Date:  2008-05       Impact factor: 2.135

6.  Differences in survival by histologic type of pancreatic cancer.

Authors:  Megan Dann Fesinmeyer; Melissa A Austin; Christopher I Li; Anneclaire J De Roos; Deborah J Bowen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-07       Impact factor: 4.254

7.  Telomere length and pancreatic cancer: a case-control study.

Authors:  Halcyon G Skinner; Ronald E Gangnon; Kristin Litzelman; Ruth A Johnson; Suresh T Chari; Gloria M Petersen; Lisa A Boardman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-23       Impact factor: 4.254

8.  Genome-wide association study of glioma and meta-analysis.

Authors:  Preetha Rajaraman; Beatrice S Melin; Zhaoming Wang; Roberta McKean-Cowdin; Dominique S Michaud; Sophia S Wang; Melissa Bondy; Richard Houlston; Robert B Jenkins; Margaret Wrensch; Meredith Yeager; Anders Ahlbom; Demetrius Albanes; Ulrika Andersson; Laura E Beane Freeman; Julie E Buring; Mary Ann Butler; Melissa Braganza; Tania Carreon; Maria Feychting; Sarah J Fleming; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Goran Hallmans; Roger Henriksson; Judith Hoffman-Bolton; Peter D Inskip; Christoffer Johansen; Cari M Kitahara; Mark Lathrop; Chenwei Liu; Loic Le Marchand; Martha S Linet; Stefan Lonn; Ulrike Peters; Mark P Purdue; Nathaniel Rothman; Avima M Ruder; Marc Sanson; Howard D Sesso; Gianluca Severi; Xiao-Ou Shu; Matthias Simon; Meir Stampfer; Victoria L Stevens; Kala Visvanathan; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Paul Decker; Victor Enciso-Mora; Brooke Fridley; Yu-Tang Gao; Matthew Kosel; Daniel H Lachance; Ching Lau; Terri Rice; Anthony Swerdlow; Joseph L Wiemels; John K Wiencke; Sanjay Shete; Yong-Bing Xiang; Yuanyuan Xiao; Robert N Hoover; Joseph F Fraumeni; Nilanjan Chatterjee; Patricia Hartge; Stephen J Chanock
Journal:  Hum Genet       Date:  2012-08-11       Impact factor: 4.132

9.  Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer.

Authors:  Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen
Journal:  Gastroenterology       Date:  2007-10-26       Impact factor: 22.682

10.  Annotation of functional variation in personal genomes using RegulomeDB.

Authors:  Alan P Boyle; Eurie L Hong; Manoj Hariharan; Yong Cheng; Marc A Schaub; Maya Kasowski; Konrad J Karczewski; Julie Park; Benjamin C Hitz; Shuai Weng; J Michael Cherry; Michael Snyder
Journal:  Genome Res       Date:  2012-09       Impact factor: 9.043

View more
  23 in total

Review 1.  Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.

Authors:  Md Abdul Aziz; Sarah Jafrin; Mohammad Safiqul Islam
Journal:  Hum Cell       Date:  2021-03-20       Impact factor: 4.174

Review 2.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

Review 3.  Lung adenocarcinoma: from molecular basis to genome-guided therapy and immunotherapy.

Authors:  Roberto Chalela; Víctor Curull; César Enríquez; Lara Pijuan; Beatriz Bellosillo; Joaquim Gea
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

4.  Identification of Pleiotropic Cancer Susceptibility Variants from Genome-Wide Association Studies Reveals Functional Characteristics.

Authors:  Yi-Hsuan Wu; Rebecca E Graff; Michael N Passarelli; Joshua D Hoffman; Elad Ziv; Thomas J Hoffmann; John S Witte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-17       Impact factor: 4.254

5.  Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer.

Authors:  Ying Bao; Jennifer Prescott; Chen Yuan; Mingfeng Zhang; Peter Kraft; Ana Babic; Vicente Morales-Oyarvide; Zhi Rong Qian; Julie E Buring; Barbara B Cochrane; J Michael Gaziano; Edward L Giovannucci; JoAnn E Manson; Kimmie Ng; Shuji Ogino; Thomas E Rohan; Howard D Sesso; Meir J Stampfer; Charles S Fuchs; Immaculata De Vivo; Laufey T Amundadottir; Brian M Wolpin
Journal:  Gut       Date:  2016-10-21       Impact factor: 23.059

6.  CLPTM1L gene rs402710 (C > T) and rs401681 (C > T) polymorphisms associate with decreased cancer risk: a meta-analysis.

Authors:  Jianzhou Tang; Changming Hu; Hua Mei; Liang Peng; Hui Li
Journal:  Oncotarget       Date:  2017-11-01

7.  Updated risk factors to inform early pancreatic cancer screening and identify high risk patients.

Authors:  Daniel R Principe; Ajay Rana
Journal:  Cancer Lett       Date:  2020-05-08       Impact factor: 9.756

8.  The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.

Authors:  Liqing Zhou; Guobin Fu; Jinyu Wei; Juan Shi; Wenting Pan; Yanli Ren; Xiangyu Xiong; Jianhong Xia; Yue Shen; Hongliang Li; Ming Yang
Journal:  Oncotarget       Date:  2016-02-02

Review 9.  Genetic factors affecting patient responses to pancreatic cancer treatment.

Authors:  George Fotopoulos; Konstantinos Syrigos; Muhammad Wasif Saif
Journal:  Ann Gastroenterol       Date:  2016-06-10

10.  TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.

Authors:  Xinyu Zhang; Yan Chen; Donglin Yan; Jing Han; Longbiao Zhu
Journal:  Biochem Genet       Date:  2021-06-28       Impact factor: 1.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.